Attention-deficit hyperactivity disorder (ADHD), or hyperkinetic disorder (HKD), is increasingly discussed in the virtual arena and at major International and European congresses focusing on mental health and psychiatry.
Shire, now part of Takeda, initiated, funded and organised a series of webinars for the ADHD healthcare community to attend, which are now available to watch on demand if you have missed the event. These on-demand webinars are hosted by leading experts in the field, and the objective is to improve the diagnosis of ADHD in adult patients with associated psychiatric conditions (e.g. bipolar disorder, major depressive disorder). These webinars cover key issues surrounding adult ADHD and comorbid psychiatric conditions, and include knowledge checks and a Q&A surrounding patient cases. There will be other webinars in the future, so look out for how to register for these live webinars on the ADHD-Institute.
There are a number of International and European congresses, such as the EUNETHYDIS International Conference on ADHD, the European College of Neuropsychopharmacology (ECNP) Congress, the European Congress of Psychiatry, the European Society for Child and Adolescent Psychiatry (ESCAP) International Congress, the World Congress on ADHD and the World Psychiatric Association (WPA) International Congress. To find out dates and locations visit the congress calendar.
Read reports from past congresses to learn more about the science of ADHD and how the disorder impacts the lives of patients, their families and the society.
Meeting of Minds is a scientific and educational meeting initiated, organised and funded by Shire, now part of Takeda, with the objective of providing a forum for ADHD scientists and clinicians to discuss the latest scientific evidence and share best practice in the management of ADHD. Read more to find out about the key discussions which occurred at the event.